These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20560778)

  • 1. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.
    Luppi B; Bigucci F; Cerchiara T; Zecchi V
    Expert Opin Drug Deliv; 2010 Jul; 7(7):811-28. PubMed ID: 20560778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.
    Gavini E; Rassu G; Muzzarelli C; Cossu M; Giunchedi P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):245-52. PubMed ID: 17574825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated chitosans: useful excipients for oral drug delivery.
    Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
    Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V
    J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
    van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
    Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
    Biomacromolecules; 2009 Feb; 10(2):243-9. PubMed ID: 19117404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review paper: chitosan derivatives as promising materials for controlled drug delivery.
    Prabaharan M
    J Biomater Appl; 2008 Jul; 23(1):5-36. PubMed ID: 18593819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan glutamate hydrogels with local anesthetic activity for buccal application.
    Pignatello R; Basile L; Puglisi G
    Drug Deliv; 2009 Apr; 16(3):176-81. PubMed ID: 19514978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S; Saupe A; McBurney W; Rades T; Hook S
    J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid polymeric hydrogels for ocular drug delivery: nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate.
    Barbu E; Verestiuc L; Iancu M; Jatariu A; Lungu A; Tsibouklis J
    Nanotechnology; 2009 Jun; 20(22):225108. PubMed ID: 19433871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
    Mei D; Mao S; Sun W; Wang Y; Kissel T
    Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
    Alhalaweh A; Andersson S; Velaga SP
    Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery.
    Gordon S; Teichmann E; Young K; Finnie K; Rades T; Hook S
    Eur J Pharm Sci; 2010 Oct; 41(2):360-8. PubMed ID: 20633644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of low molecular drugs using chitosan and its derivatives.
    Park JH; Saravanakumar G; Kim K; Kwon IC
    Adv Drug Deliv Rev; 2010 Jan; 62(1):28-41. PubMed ID: 19874862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable chitosan hydrogels for localised cancer therapy.
    Ta HT; Dass CR; Dunstan DE
    J Control Release; 2008 Mar; 126(3):205-16. PubMed ID: 18258328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.